Kiran Kumar Solingapuram Sai to Alzheimer Disease
This is a "connection" page, showing publications Kiran Kumar Solingapuram Sai has written about Alzheimer Disease.
Connection Strength
0.486
-
Erichsen JM, Register TC, Sutphen C, Ma D, Gaussoin SA, Rudolph M, Rundle M, Bateman JT, Lockhart SN, Sai KKS, Whitlow C, Craft S. A phase 2A/B randomized trial of metabolic modulators intranasal insulin and empagliflozin for MCI and early AD. Alzheimers Dement. 2025 Oct; 21(10):e70704.
Score: 0.183
-
Damuka N, Lockhart SN, Solingapuram Sai KK. Imaging microtubule dynamics: A new frontier in biomarker development for neurodegenerative diseases. Alzheimers Dement. 2025 Sep; 21(9):e70670.
Score: 0.182
-
Neth BJ, Mintz A, Whitlow C, Jung Y, Solingapuram Sai K, Register TC, Kellar D, Lockhart SN, Hoscheidt S, Maldjian J, Heslegrave AJ, Blennow K, Cunnane SC, Castellano CA, Zetterberg H, Craft S. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study. Neurobiol Aging. 2020 02; 86:54-63.
Score: 0.121